NDC 0268-8200

OTIPRIO

Otiprio

OTIPRIO is a Intratympanic Suspension in the Human Prescription Drug category. It is labeled and distributed by Alk-abello, Inc.. The primary component is Ciprofloxacin.

• Product ID: 0268-8200_3ff889ae-1127-46ac-a1cc-13c1e38840f3
• NDC: 0268-8200
• Product Type: Human Prescription Drug
• Proprietary Name: OTIPRIO
• Generic Name: Otiprio
• Dosage Form: Suspension
• Route of Administration: INTRATYMPANIC
• Marketing Start Date: 2022-04-04
• Marketing End Date: 2022-12-31
• Marketing Category: NDA /
• Application Number: NDA207986
• Labeler Name: ALK-Abello, Inc.
• Substance Name: CIPROFLOXACIN
• Active Ingredient Strength: 60 mg/mL
• Pharm Classes: Quinolone Antimicrobial [EPC], Quinolones [CS]
• NDC Exclude Flag: N

Packaging

NDC 0268-8200-01

1 VIAL, SINGLE-USE in 1 CARTON (0268-8200-01) > 1 mL in 1 VIAL, SINGLE-USE

• Marketing Start Date: 2022-04-04
• Marketing End Date: 2022-12-31
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "OTIPRIO" or generic name "Otiprio"

NDC	Brand Name	Generic Name
0268-8200	OTIPRIO	OTIPRIO
69251-201	Otiprio	ciprofloxacin